in this issue
People & Business :: Companies
Pfizer Completes $68-Billion Wyeth Acquisition
1:54 PM MDT | October 29, 2009 | Deepti Ramesh
Pfizer says it has completed its previously announced acquisition of Wyeth for $68 billion, following the receipt of regulatory approval from all government authorities required by the merger agreement, and approval by Wyeth shareholders. Pfizer agreed to acquire Wyeth in January 2009. Pfizer and Wyeth have begun joint operations from October 16, 2009. The combined company has strengthened capabilities in biotechnology, vaccines, consumer healthcare, nutrition and animal health, and it is expected that no drug will account for more than 10% of the combined...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee